Catherine Verfaillie

Catherine Verfaillie (b. Ypres, 1957) is a Belgian molecular biologist and professor at the Katholieke Universiteit Leuven (Leuven, Belgium).

Education
She obtained an M.D.from the Katholieke Universiteit Leuven in 1982, after which she specialized in internal medicine and became interested in hematology and leukemia.

Career
In 1987 she departed for the U.S. as a research-fellow to the University of Minnesota. She worked in the lab of Dr. Phillip McGlave in hematopoiesis and stromal control of hematopoietic stem cells, in 1991 becoming a professor in the Department of Medicine, becoming a full professor in 1997.

Catherine Verfaillie was Director of the Stem Cell Institute at the University of Minnesota (U.S.) from 1998 until 2006. She discovered multipotent adult progenitor cells (MAPC), a type of adult stem cell.

She is a Professor of Medicine in the Division of Hematology, Oncology and Transplantation of the University of Minnesota Medical School. She holds the Anderson Chair in Stem Cell Biology and the McKnight's Presidential Chair in Stem Cell Biology.

She now leads the Stamcel Instituut te Leuven (SCIL) (E: Stem Cell Institute Leuven) at the Katholieke Universiteit Leuven in Leuven, Belgium.

Honors

 * José Carreras-prize
 * Damasheck-prize
 * 2005, Vlerick Award

Source

 * Catherine Verfaillie (UMN)
 * Catherine Verfaillie (KUL)
 * Stem Cell Institute Leuven (SCIL, KUL)